IL1B and lung disorder: In order to demonstrate the validity of the in vitro THP-1 model as a valuable tool in revealing possible bioactive nanomaterials, a regression analysis of IL-1β release at 25 mg/ml in the THP-1 cells to pathology scores was done (Figure 12), using the THP-1 results as the predictor variable for lung disease.